2013-04-19 07:00:08 CEST

2013-04-19 07:01:11 CEST


REGULATED INFORMATION

English Finnish
Raisio - Company Announcement

Raisio sold its esterification plant in the U.S.A


Raisio plc      Stock Exchange Release, 19 April 2013

RAISIO SOLD ITS ESTERIFICATION PLANT IN THE U.S.A

Raisio has sold its US esterification plant to Avoca Inc, a subsidiary of
Pharmachem Laboratories Inc. The agreement was signed and transaction closed on
18 April 2013. With the deal, the production of plant stanol ester, a Benecol
product ingredient, will be centralised to the Raisio-based factory and
profitability will improve according to the Group objective. 

Raisio built the esterification plant in Summerville, South-Carolina, in 1998.
Summerville factory has operated as a reserve plant with low volumes. In 2012,
net sales of the factory totalled approximately EUR 3.2 million excluding the
production of plant stanol ester, a Benecol product ingredient, not part of the
transaction. The factory employs 19 persons. 

Avoca is a division of Pharmachem Laboratories headquartered in Kearny, New
Jersey. Pharmachem Laboratories is an international innovator, manufacturer and
supplier of high-quality ingredients. Avoca is a custom developer and
manufacturer of extraction products and services. For 40 years, Avoca has
worked closely with, e.g., some of the world's outstanding flavour and
fragrance companies. Avoca's net sales in 2012 were approximately USD 60
million. 

Benecol is a global trademark owned by Raisio, and plant stanol ester is an
ingredient patented worldwide by Raisio. Benecol products are sold and marketed
by Raisio's wide partner network in some 30 countries on five continents. Net
sales of Benecol business totalled EUR 45 million in 2012. 

RAISIO PLC

Heidi Hirvonen
Communications and IR Manager
tel. +358 50 567 3060

Further information:
Mikko Laavainen, COO, Benecol, tel. +358 40 576 8348